TAF vs. TDF: Measuring Lipid Levels in HIV Treatment
November 22nd 2019TAF causes cholesterol levels to rise, but that includes levels of “good cholesterol” HDL. Researchers concluded that there is no significant difference in cardiovascular risk profiles between people taking TAF and those taking TDF.
Read More
Early Intervention Programs Can Link Incarcerated Individuals to HIV Care Prior to Release
November 10th 2019Inmates at an NJ facility have their HIV treatment needs met while incarcerated but the lack of transitional care coordination has led many individuals to fall off of the care continuum upon release.
Read More
Gaps Exist Between Perceived and Actual CVD Risk in People with HIV
November 9th 2019Perceived and actual risk of cardiovascular disease is only weakly associated in people living with HIV. An analysis reveals that provider CVD risk discussion is significantly associated with perception of CVD susceptibility.
Read More